Status:

UNKNOWN

Telocytes in Placental Tissues of Patients With Gestational and Pre-gestational Diabetes

Lead Sponsor:

Sohag University

Conditions:

Diabetes in Pregnancy

Eligibility:

FEMALE

18-45 years

Brief Summary

Examining the expression of telocytes in the placental tissues and umbilical cord of patients with gestational or pregestational diabetes during pregnancy compared to control.

Detailed Description

this is an observational study, patients with gestational or pre-gestational diabetes undergoing elective (pre-labour) Cesarean section will be asked to participate in the study. Samples of placenta a...

Eligibility Criteria

Inclusion

  • All pregnant women presented at the delivery ward in Sohag University Hospital, Sohag, Egypt with the following criteria:
  • Study group: Singleton pregnancies complicated with diabetes undergoing pre-labour CS at gestational age (37+0 to 40+0). These will be divided into 3 groups according to the type of disease either Gestational diabetes (Group A), pregestational diabetes type 1 (Group B) or type 2 (Group C). 2-Control group: Singleton pregnancies undergoing elective pre-labour CS at gestational age (37+0 to 40+0) that are otherwise healthy

Exclusion

  • Women with history of medical co-morbidities other than diabetes are excluded from the study. This includes the following: Chronic hypertension, renal diseases, autoimmune diseases, history of organ transplantation and immunosuppressive therapy, hematological diseases, history of thrombotic events, cardiopulmonary diseases, liver diseases Acute and chronic inflammatory diseases.
  • Pregnancy induced medical disorders like: Gestational hypertension, preeclampsia, Gestational thrombocytopenia, and proteinuria.
  • Multiple pregnancies.
  • Abnormal placentation, i.e. Placenta previa and Morbidly adherent placenta.
  • Fetal anomalies.
  • vaginal deliveries and CS in labor.
  • Spontaneous delivery.

Key Trial Info

Start Date :

December 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05305326

Start Date

December 1 2021

End Date

December 31 2022

Last Update

March 31 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sohag Faculty of Medicine

Sohag, Egypt, 82514